Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Berman

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Science (New York, N.Y.)|August 31, 2002
Medulloblastoma growth inhibition by hedgehog pathway blockadeDavid M Berman, Sunil S Karhadkar, Andrew R Hallahan, et al.
Annals of the New York Academy of Sciences|June 19, 2013
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanomaJedd D Wolchok, F Stephen Hodi, Jeffrey S Weber, et al.
European Urology Focus|March 27, 2021
International Society of Urological Pathology Expert Opinion on Grading of Urothelial CarcinomaTheo van der Kwast, Fredrik Liedberg, Peter C Black, et al.
European Urology|July 19, 2018
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective TrialLaurence Klotz, Andrew Loblaw, Linda Sugar, et al.
The Prostate|April 19, 2019
PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cellsThiago Vidotto, Fabiano P Saggioro, Tamara Jamaspishvili, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2020
Building a Canadian Translational Bladder Cancer Research NetworkMadhuri Koti, David M Berman, D Robert Siemens, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2014
PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomyTamara L Lotan, Filipe Lf Carvalho, Sarah B Peskoe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohortsStephanie A Harmon, Palak G Patel, Thomas H Sanford, et al.
British Journal of Cancer|April 10, 2023
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patientsWalead Ebrahimizadeh, Karl-Philippe Guérard, Shaghayegh Rouzbeh, et al.
Cancer Immunology Research|June 25, 2024
Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non-Muscle Invasive Bladder CancerPriyanka Yolmo, Sadaf Rahimi, Stephen Chenard, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Science (New York, N.Y.)|August 31, 2002
Medulloblastoma growth inhibition by hedgehog pathway blockadeDavid M Berman, Sunil S Karhadkar, Andrew R Hallahan, et al.
Annals of the New York Academy of Sciences|June 19, 2013
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanomaJedd D Wolchok, F Stephen Hodi, Jeffrey S Weber, et al.
European Urology Focus|March 27, 2021
International Society of Urological Pathology Expert Opinion on Grading of Urothelial CarcinomaTheo van der Kwast, Fredrik Liedberg, Peter C Black, et al.
European Urology|July 19, 2018
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective TrialLaurence Klotz, Andrew Loblaw, Linda Sugar, et al.
The Prostate|April 19, 2019
PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cellsThiago Vidotto, Fabiano P Saggioro, Tamara Jamaspishvili, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2020
Building a Canadian Translational Bladder Cancer Research NetworkMadhuri Koti, David M Berman, D Robert Siemens, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2014
PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomyTamara L Lotan, Filipe Lf Carvalho, Sarah B Peskoe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohortsStephanie A Harmon, Palak G Patel, Thomas H Sanford, et al.
British Journal of Cancer|April 10, 2023
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patientsWalead Ebrahimizadeh, Karl-Philippe Guérard, Shaghayegh Rouzbeh, et al.
Cancer Immunology Research|June 25, 2024
Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non-Muscle Invasive Bladder CancerPriyanka Yolmo, Sadaf Rahimi, Stephen Chenard, et al.
Pageof 13